Full Text View
Tabular View
No Study Results Posted
Related Studies
Use of Pharmacotherapy to Reduce Cue-Responsiveness in Smokers
This study has been completed.
Study NCT00133757   Information provided by Centre for Addiction and Mental Health
First Received: August 23, 2005   Last Updated: September 12, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nicotine Dependence
Tobacco Dependence
Additional conditions recognized in this trial
Tobacco Use Disorder
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Bupropion SR
Additional drug interventions recognized in this trial
Bupropion
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Sponsors listed in this trial
Centre for Addiction and Mental Health
Canadian Institutes of Health Research (CIHR)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services